Aquavit Pharmaceuticals

Media

AQUAGOLD® fine touch Presented at the 2014 International Master Course on Aging Skin (IMCAS) by Dr. David Goldberg

Paris, France, February 5, 2014

AQUAGOLD® fine touch was featured at the 2014 International Master Course on Aging Skin Conference (IMCAS) in Paris during a session on “Clinical Evaluation of the Efficacy and Tolerance of Combining a Topical Tightening Agent with Devices" . Dr. David Goldberg, Director, Skin Laser & Surgery Specialists of NY/NJ and Clinical Professor and Director of Laser Research in the Department of Dermatology at the Mount Sinai School of Medicine, presented and discussed AQUAGOLD® fine touch, a unique microneedle device that effectively and comfortably delivers small droplets of treatment solutions directly into the skin allowing for greater absorption of the active ingredients than traditional delivery methods. AQUAGOLD® fine touch treatments can address fine lines, increase collagen stimulation and improve overall moisture and rejuvenation of the skin. “AQUAGOLD® fine touch will provide a very nice complement to other injectables or laser procedures given its design which allows for a broad option of treatment solutions to be used with the device”, said Dr. Goldberg.

Dr. David Goldberg has chaired many academic societies and is currently serving as Chairman of American Society for Lasers in Medicine and Surgery Ethics Committee. “IMCAS is a very significant event, attracting world class thought leaders. We are honored to have Dr. Goldberg present AQUAGOLD® fine touch as our European debut. This early strong level of attention from key opinion leaders such as Dr. Goldberg bodes well for the future of our product in the market. Given the reception the product has received so far, we look forward to debuting AQUAGOLD® fine touch at the American Academy of Dermatology in Denver in March.”, said Sobin Chang, CEO of Aquavit Pharmaceuticals. AQUAGOLD® fine touch is first-of-its-kind, FDA and CE Mark registered direct dermal application device.

About Aquavit Pharmaceuticals, Inc.

Aquavit Pharmaceuticals is a multi-specialty healthcare company focused on discovering, developing and commercializing innovative pharmaceuticals, medical devices and health technologies. For more information, visit www.aquavitpharma.com or www.aquagoldfinetouch.com.

About David Goldberg, M.D.

David J. Goldberg, M.D. is recognized nationally and internationally for his innovative work with skin lasers, cosmetic dermatology and facial rejuvenation techniques. A board-certified dermatologist who has been in practice since 1985, he has treated patients and taught doctors throughout the world in the use of these cutting-edge technologies. Dr. Goldberg is active in professional societies and was elected president of the American Society for Lasers in Medicine & Surgery. Dr. Goldberg was recently elected to the board of directors of the American Academy of Dermatology and Secretary to the board of directors of the American Society for Dermatologic Surgery. He also serves as a co-vice-president of the Skin Cancer Foundation. Dr. Goldberg was the first recipient of the prestigious Leon Goldman award, named after the founder of laser surgery.